[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Safety of COVID-19 vaccines: spotlight on neurological complications

G Tondo, E Virgilio, A Naldi, A Bianchi, C Comi - Life, 2022 - mdpi.com
The COVID-19 pandemic has led to unprecedented demand on the global healthcare
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …

Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the vaccine safety datalink

KE Hanson, K Goddard, N Lewis, B Fireman… - JAMA network …, 2022 - jamanetwork.com
Importance Postauthorization monitoring of vaccines in a large population may detect rare
adverse events not identified in clinical trials such as Guillain-Barré syndrome (GBS), which …

[HTML][HTML] Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad. 26. COV2. S (Janssen [Johnson & Johnson]) vaccine dose against …

K Natarajan - MMWR. Morbidity and Mortality Weekly Report, 2022 - cdc.gov
VE against COVID-19–associated emergency department/urgent care visits was 24% after 1
Jansen dose, 54% after 2 Jansen doses, and 79% after 1 Janssen/1 mRNA dose, compared …

Imperfect messengers? An analysis of vaccine confidence among primary care physicians

T Callaghan, D Washburn, K Goidel, T Nuzhath… - Vaccine, 2022 - Elsevier
Background Growing narratives emphasize using primary care physicians as leaders in
efforts to promote COVID-19 vaccination among the vaccine hesitant. Critically however …

COVID-19, vaccines, and thrombotic events: a narrative review

MG Abrignani, A Murrone, L De Luca, L Roncon… - Journal of clinical …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

[HTML][HTML] COVID-19 Vaccine Safety Technical (VaST) Work Group: enhancing vaccine safety monitoring during the pandemic

LE Markowitz, RH Hopkins Jr, KR Broder, GM Lee… - Vaccine, 2024 - Elsevier
During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for
potential use in the United States on an unprecedented, accelerated schedule. It was …

COVID-19 therapeutics: use, mechanism of action, and toxicity (vaccines, monoclonal antibodies, and immunotherapeutics)

M Chary, AF Barbuto, S Izadmehr, M Tarsillo… - Journal of Medical …, 2023 - Springer
SARS-CoV-2 emerged in December 2019 and led to the COVID-19 pandemic. Efforts to
develop therapeutics have led to innovations such as mRNA vaccines and oral antivirals …

Profiling COVID-19 vaccine adverse events by statistical and ontological analysis of VAERS case reports

W Guo, J Deguise, Y Tian, PCE Huang… - Frontiers in …, 2022 - frontiersin.org
Since the beginning of the COVID-19 pandemic, vaccines have been developed to mitigate
the spread of SARS-CoV-2, the virus that causes COVID-19. These vaccines have been …

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine …

M Wallace, HG Rosenblum, DL Moulia, KR Broder… - Vaccine, 2023 - Elsevier
Abstract To inform Advisory Committee for Immunization Practices (ACIP) COVID-19 vaccine
policy decisions, we developed a benefit-risk assessment framework that directly compared …